Compare CASH & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CASH | LMAT |
|---|---|---|
| Founded | 1954 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1996 | 2006 |
| Metric | CASH | LMAT |
|---|---|---|
| Price | $91.23 | $103.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $107.50 | $105.80 |
| AVG Volume (30 Days) | 195.0K | ★ 250.9K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | 0.23% | ★ 0.93% |
| EPS Growth | 18.88 | ★ 30.57 |
| EPS | ★ 4.89 | 0.68 |
| Revenue | ★ $839,894,000.00 | $249,602,000.00 |
| Revenue This Year | $7.56 | $14.21 |
| Revenue Next Year | $6.02 | $8.88 |
| P/E Ratio | ★ $18.56 | $152.37 |
| Revenue Growth | 11.29 | ★ 13.53 |
| 52 Week Low | $65.93 | $79.40 |
| 52 Week High | $101.26 | $118.01 |
| Indicator | CASH | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | N/A |
| Support Level | $86.45 | N/A |
| Resistance Level | $94.61 | N/A |
| Average True Range (ATR) | 2.49 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 82.42 | 0.00 |
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.